Evidence map›Paper›PMID 28586400›Full record

ArticlePloS one2017

Patients with schizophrenia activate behavioural intentions facilitated by counterfactual reasoning.

Fernando Contreras, Auria Albacete, Cristian Tebé, Bessy Benejam, Agnes Caño, José Manuel Menchón

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fernando ContrerasDepartment of Psychiatry, Bellvitge University Hospital- IDIBELL, L'Hospitalet de Llobregat, Spain.
Auria AlbaceteDepartment of Psychiatry, Bellvitge University Hospital- IDIBELL, L'Hospitalet de Llobregat, Spain.
Cristian TebéStatistical Advisory Service, Bellvitge Biomedical Institute-IDIBELL, L'Hospitalet de Llobregat, Spain.
Bessy BenejamDepartment of Psychiatry, Bellvitge University Hospital- IDIBELL, L'Hospitalet de Llobregat, Spain.
Agnes CañoDepartment of Psychology, University of Girona, Girona, Spain.
José Manuel MenchónDepartment of Psychiatry, Bellvitge University Hospital- IDIBELL, L'Hospitalet de Llobregat, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

methodThe main variables assessed were: answer to complete a target task (wrong or correctly), and percentage gain in the reaction time (RT) to complete a target task correctly depending on whether the prime was a counterfactual or a neutral-control cue. These variables were assessed in 37 patients with schizophrenia and 37 healthy controls. Potential associations with clinical status and socio-demographic characteristics were also explored.

resultsWhen a counterfactual prime was presented, the probability of giving an incorrect answer was lower for the entire sample than when a neutral prime was presented (OR 0.58; CI 95% 0.42 to 0.79), but the schizophrenia patients showed a higher probability than the controls of giving an incorrect answer (OR 3.89; CI 95% 2.0 to 7.6). Both the schizophrenia patients and the controls showed a similar percentage gain in RT to a correct answer of 8%.

conclusionsChallenging the results of previous research, our findings suggest a normal activation of behavioural intentions facilitated by CFT in schizophrenia. Nevertheless, the patients showed more difficulty than the controls with the task, adding support to the concept of CFT as a potential new target for consideration in future therapeutic approaches for this illness.

Indexed as

Neuropsychological TestsAdultCognition DisordersCognitive DysfunctionFemaleHumansLearningMaleMiddle AgedReaction TimeSchizophrenia

Identifiers

PMID28586400
PMCPMC5460856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.